Dupixent and Cutaneous T-Cell Lymphoma: What Patients Should Know About the Growing Litigation

Start
Dupixent (dupilumab) is one of the most widely prescribed biologic medications in the United States. Doctors use it to treat moderate to severe eczema, also called atopic dermatitis, along with asthma, chronic sinus conditions, and other inflammatory diseases. For many patients, it has offered real relief from stubborn, itchy skin….
By: Hissey, Mulderig & Friend, PLLC
Previous Story

Federal Court Rejects Industry-Wide Liability Theory in Ultra-Processed Food Lawsuit

Next Story

Featured Conversations… Key Takeaways from A.M. Best’s Webinar on the Misuse Defense in Product Liability Claims